Cell, Vol. 66, 1217-1226,

September

20, 1991, Copyright

0 1991 by Cell Press

Human Cyclin E, a New Cyclin That Interacts with Two Members of the CDC2 Gene Family Andrew Koff,” Fred Cross,t Alfred Fisher, * Jill Schumacher, l Katherine Leguellec,* Michel Philippe,* and James M. Roberts’ *Department of Basic Sciences Fred Hutchinson Cancer Research Center 1124 Columbia Street Seattle, Washington 98104 tRockefeller University New York, New York 10021-6399 *Laboratoire de Biologie et Genetique du Developpement Centre National de la Recherche Scientifique Unite Associee 256 Universite de Rennes I Campus de Beaulieu 35042 Rennes Cedex France

Summary A new human cyclin, named cyclin E, was isolated by complementation of a triple c/n deletion in S. cerevisiae. Cyclin E showed genetic interactions with the CDC28 gene, suggesting that it functioned at START by interacting with the CDC28 protein. Two human genes were identified that could interact with cyclin E to perform START in yeast containing a cdc28 mutation. One was CDC2-HS, and the second was the human homolog of Xenopus CDK2. Cyclin E produced in E. coli bound and activated the CDC2 protein in extracts from human Gl cells, and antibodies against cyclin E immunoprecipitated a histone Hl kinase from HeLa cells. The interactions between cyclin E and CDCZ, or CDKP, may be important at the Gl to S transition in human cells. Introduction Molecules that regulate the onset of mitosis have been highly conserved in evolution (reviewed in Nurse, 1990; Cross, 1990). In Saccharomyces cerevisiae the product of the CDC28 gene and in Schizosaccharomyces pombe the cdc2+ gene product is required for entry into mitosis (Nurse and Bisset, 1981; Piggot et al., 1982; Reed and Wittenberg, 1990). The cdc2 and CDC28 gene products are structurally similar (Lorincz and Reed, 1984; Hindley and Phear, 1984) and functionally homologous (Beach et al., 1982; Booher and Beach, 1987). They encode a serinel threonine protein kinase that is the homolog of the 34 kd protein kinase in vertebrate and invertebrate MPF (Lee and Nurse, 1987; Arion et al., 1988; Dunphy et al., 1988; Gautier et al., 1988; Labbe et al., 1988). The activity of the p34 CDC2 kinase oscillates during the cell cycle (Mendenhall et al., 1987; Draettaand Beach, 1988; Labbe et al., 1989b; Moreno et al., 1989; Pines and Hunter, 1990). This is not controlled by variations in the

amount of the CDC2 gene product (Durkacz et al., 1986; Simanis and Nurse, 1986; Draetta and Beach, 1988) but rather by its interactions with other proteins, including the cyclins (Rosenthal et al., 1980; Evans et al., 1983; Swenson et al., 1986; Draetta et al., 1989; Meijer et al., 1989; Minshull et al., 1989; Labbe et al., 1989a; Solomon et al., 1990; Gautier et al., 1990; reviewed in Murray and Kirschner, 1989; Hunt, 1989). Association between the p34 CDC2 protein and the B-type cyclins is necessary for the activation of the p34 kinase at the onset of mitosis in a wide variety of organisms including yeast (Booher and Beach, 1987; Hagan et al., 1988; Moreno et al., 1989; Solomon et al., 1988; Booher et al., 1989; Surana et al., 1991; Ghiaraetal., 1991)andhumans(Draettaand Beach, 1988; Pines and Hunter, 1989; Riabowol et al., 1989). In yeast the Gl IS transition, called START, also requires the CDC28 or cdc2 gene product (Hartwell et al., 1973, 1974; Nurse and Bisset, 1981). The biochemical pathways that activate CDC28 at START are not completely understood but the recent identification of Gl-specific cyclins in yeast, the CLNl, -2, and -3 proteins, suggests that Gl/S activation and G2/M activation of CDC28 share common features (Sudbery et al., 1980; Nash et al., 1988; Cross, 1988,199O; Hadwigeret al., 1989; Richardson et al., 1989; Wittenberg et al., 1990). Cells deficient in all three CLN proteins arrest at START; they continue to grow but are unable to enter S phase. The CLNP protein (and probably CLNl and -3) forms a complex with the CDC28 kinase at START (Wittenberg et al., 1990). Like the mitotic cyclins, to which they show limited but significant homology, the abundance of the CLNl and -2 proteins oscillates during the cell cycle, but maximal levels are observed in late Gl rather than late G2 (Wittenberg et al., 1990). Very little is known about the biochemical pathways that control thestartof DNAsynthesisin highereukaryoticcells or the extent to which these pathways resemble those in yeast. In human cells, as in budding yeast, the predominant mode of control of cell proliferation occurs during the Gl phase of the cell cycle (Zetterberg and Larson, 1985; Zetterberg, 1990). The kinetics of passage through Gl in mammalian cells suggests that a single decision, called the restriction point, regulates commitment to DNA synthesis (Pardee, 1974). Prior to the restriction point, progress through Gl is very sensitive to the growth state of the cell. Reducing the rate of protein synthesis or removal of specific extracellular growth factors will delay entry into S phase and can even cause cell cycle arrest. After the restriction point the cell cycle becomes substantially less responsive to these signals (reviewed in Pardee, 1989). These features of mammalian cell growth control are very reminiscent of the size control of cell division that characterizes START in budding yeast, although in the mammalian cell cycle responsiveness to extracellular growth factors seems more prominent and strictly size-dependent proliferation less so. The similarities between the restriction point and START have suggested the hypothesis that activation of the p34

Cell 1218

GALACTOSE

Figure 1. Complementation of the Triple c/n Deletion by Human Cyclin E

GLUCOSE

589

S. cerevisiae strain 589-5 contains deletions of the chromosomal CLNl, -2, and -3 genes and contains the GAL7-CLN3 gene on a multicopy episome. It was transformed with the pADNS expression vector or the pADNS vector containing a human cyclin E cDNA. Transformants, and the parental strain, were streaked on galactose and glucose and grown for 3 days at 30%.

589-5 +pRONS

589-S

l pRONS-WC

E

589-S +pRONS-CVC

CDCP kinase plays a central role in regulating mammalian cell proliferation at the Gl to S transition. Indeed, the human CDCP gene can substitute for the S. pombe cdc2 gene for both its GllS and G2/M roles (Lee and Nurse, 1987). Cell fusion experiments offer circumstantial evidence in support of this hypothesis (Rao and Johnson, 1970). These experiments showed that a diffusible, transacting factor activated DNA synthesis when S phase cells were fused to Gl cells. The relationship between the S phase activator operationally defined by those experiments and the p34 CDCP kinase remains unclear. Some recent observations lend direct experimental support to the hypothesis that the p34 CDC2 kinase plays a necessary role in the Gl to S phase transition during the human cell cycle. We isolated cyclin-CDC2 complexes in human S phase cells and showed that they could activate SV40 DNA replication when added to extracts from Gl cells (D’Urso et al., 1990). Others have shown that depletion of CDC2 protein from Xenopus extracts can block DNA replication (Blow and Nurse, 1990). Also, antisense oligonucleotidesdirected against the human CDC2 mRNA can prevent primary human T cells from entering S phase following activation with phytohemagglutinin (Furakawa et al., 1990). The pathway that activates the p34 kinase during the Gl phase of the human cell cycle is not understood. By analogy with the CLN-dependent activation of CDC28 at START, it is expected that specific Gl cyclins play a role in regulating the human p34 kinase during the Gl to S phase transition. We have begun to test this idea by determining whether human cells contain specific cyclins that can replace the S. cerevisiae CLN proteins. This assay identified a new human cyclin, cyclin E. Results Complementation of a Yeast Strain Lacking CLNI, -2, and -3 with a Human cDNA Library Our initial goal was to identify human cDNAs encoding proteins that could substitute for the yeast CLN proteins. A yeast strain, 589-5, was constructed in which all three chromosomal CLN genes were deleted and which contained the CLN3 gene under the control of the GAL1 promoter on an episome. As CLN protein is required for passage through START, this strain will grow on galactose, where the GAL7 promoter is induced; when this strain is

E

grown on glucose the GAL7 promoter is repressed, no CLN3 protein is made, and the cells arrest at START (Cross, 1990). A cDNA library (a gift of J. Colicelli and M. Wigler), using mRNA prepared from the human glioblastoma cell line U118, was constructed in an S. cerevisiae vector containing the constitutive yeast ADH promoter for expression of the human cDNAs (Colicelli at al., 1989). The library was transfected into strain 589-5, and 1 O5independent transformants were screened, by replica plating, fortheirabilitytogrowonglucose.One transformant, HU4, was isolated whose growth on glucose was dependent on expression of a human cDNA (Figure 1). HU4 Encodes a New Member of the Cyclin Protein Family The DNA sequence of the 1.7 kb HU4 cDNA is shown in Figure 2, and its homology, at the protein level, to human cyclins A and B illustrated in Figure 3. The DNA sequence predicts a protein with 395 amino acids and a molecular weight of 45,120. In vitro transcription/translation of the HU4 cDNA yields a protein with the predicted molecular weight (see Figure 5). All known cyclins have a highly conserved central domain of approximately 87 amino acids. HU4 is 49% identical to human cyclin A and 44% identical to human cyclin B within this domain. On this basis we placed the HU4 protein within the cyclin family. N-terminal to this conserved region the homology to cyclin A falls to 5% identity, and 4% identity to cyclin 8. C-terminal to this domain the identity to cyclin A is 14%, and the identity to cyclin B is 10%. This low level of homology both N- and C-terminal to the central conserved domain suggests that HU4 represents a new class of cyclin proteins, and we have designated this class as cyclin E. We cannot be certain that our cyclin E cDNA clone contains the entire cyclin E protein coding sequence, as the open reading frame extends to the 5’ end of the sequenced cDNA. However, a cyclin E cDNA clone obtained from a MANCA cell library showed a 5’ end identical to the one described here (J. S. and J. M. R., unpublished data). Human Cyclin B Complements the Triple c/n Deletion We compared the ability of human cyclin A, B, and E cDNAs to complement the triple c/n deletion in strain 5895. Full-length cDNA clones encoding human cyclins A (Pines and Hunter, 1990) and Bl (Pines and Hunter, 1989)

$~~lmgan Cyclin E

gtgctcacccggcccggtgccacccgggtccacagggatgcgaaggagcgggacacc

0

atg met

aag gag gac lys glu asp

61

act thr

gtt va:

ttt phe

121

tag gin

tgt cys

181

ccc pro

aca cct thr pro

241

att ile

att ile

gca ala

301

gtc vat

tgg trp

361

caa cat gin his

421

ggc gly

ggc gly

gcg ala

gag ttc glu phe

tcg ser

get ala

cgc arg

tee ser

egg erg

aag egg lys arg

ttg tag Leu gin

gat asp

cca pro

gat asp

gaa gaa atg glu glu met

gee ala

aaa lys

ate ile

gac asp

ggg age tag gly ser gln

cct pro

tgg trp

gac aat asp asn

gca gtc ala val

tgt cys

gca gac ccc ala asp pro

gac asp

aaa’gaa lys glu

gat asp

gat asp

gac egg gtt asp arg val

tat tyr

cca pro

sac asn

cca pro

tee ser

aga ggc arg gly

tee ser

ccg pro

gta val

ctg leu

aaa ate Lys ile

atg met

tta leu

sac asn

aag gas lys glu

aag aca tat lys thr tyr

cct pro

ctt leu

ctg leu

tag gln

cca pro

aaa atg lys met

cga gca arg ala

tgt cys

gaa gtc glu vat

tat tyr

aaa lys

ctt leu

cat his

agg gag act arg gfu thr

tat tyr

atg met

gcg ala

aca caa thr gln

gaa aat glu asn

gtt val

541

tta \eu

ttt phe

att ile

gca ala

aaa lys

ctt teu

601

gtg val

aca thr

gat asp

gga get gly ala

tgt cys

661

gee ala

ctt leu

aag tgg tys trp

cgt arg

721

gtt val

gca tat ala tyr

eta leu

781

ata ile

tag gln

841

tat tyr

901

aag gca lys ala

gtg vat

gcg ala

agg gac arg asp

tee ser

ctg leu

ate ife

acg tgc thr cys

aag cct f.ys pro

egg arg

age tgg ser trp

gca ala

eat asn

aga gag gaa arg glu glu

tta leu

agg gat arg asp

tag gin

cat his

ttt phe

ctt leu

att ile

ctt Leu

ctg leu

tgg trp

tta leu

atg met

gag gtg glu va(

ttt phe

tat tyr

ttg leu

gca caa gat ala gin asp

ttc phe

ttt phe

gac egg asp arg

aaa act lys thr

ctt teu

tta leu

tag gin

ctt leu

att ile

ggg att gly ile

tea ser

tct ser

gag gaa gfu giu

ate ite

tat tyr

cct pro

cca pro

aag lys

ttg \eu

cat his

tag gln

ttt phe

gcg ala

tat tyr

tea ser

gga gat gly asp

gaa glu

att ile

ctc teu

act thr

atg met

gaa glu

tta leu

atg met

att ile

atg met

aag Lys

tta leu

agt ser

ccc pro

ctg act Leu thr

att ile

gtg val

tee ser

tgg trp

ctg leu

aat asn

gta val

tat tyr

atg met

tag gin

aat asn

gac asp

tta leu

cat his

gaa gtg glu val

eta leu

ctg teu

ccg pro

tag gln

tat tyr

ccc pro

tag gln

caa gin

ate ile

ttt phe

att ile

gca gag ala glu

ctg leu

ttg leu

gat asp

ctc leu

tgt cys

gtc vat

ctg leu

gat asp

gtt val

gac tgc asp cys

ctt leu

gaa ttt glu phe

cct pro

ggt gly

ata ile

ctt leu

get ala

get ala

tcg ser

gee ttg ala teu

tat tyr

cat his

ttc phe

tcg ser

tea ser

tct ser

gaa glu

ttg leu

atg met

caa gin

aag lys

gtt val

tea ser

ggg tat gly tyr

tag gin

tgg trp

tgc cys

gac asp

gag sac glu asn

tgt cys

gtc val

aag tgg lys trp

atg met

gtt vat

cca pro

ttt phe

gee ala

961

atg met

gtt val

ata ile

agg gag arg glu

acg thr

ggg age tea gly ser ser

aaa fys

ctg leu

aag cat lys his

ttc phe

agg ggc gtc arg gly val

get ala

gat asp

gaa glu

1021

gat asp

gca ala

cat his

sac asn

ata ile

tag gin

act thr

aga gac arg asp

age ser

ttg feu

gat asp

ttg leu

ctg leu

gac asp

aaa gee cga lys ala arg

gca ala

1081

aag lys

aaa gee atg fys ala met

ttg leu

tct ser

gaa caa gfu gin

aat asn

agg get arg ala

tct ser

cct pro

ctc leu

ccc pro

agt ser

ggg gly

act thr

1141

ccg pro

cm pro

aag Lys

sag tag

age age ggg ccg ser ser gly pro

tag gin

gee ala

age ggt ser gly

lys

cat his

gin

gta vat

ata ile

aat asn

ctg leu

cct pro

gas atg glu met

tea ser

gat asp

agg acg arg thr

sac asn

gcg tga ala ***

ccaccaaagacagttgcgcgcctgctccacgttctcttctgtctgttgcagcggaggcgtgcgtttgcttttacagata tctgaatggaagagtgtttcttccacaacagaagtatttctgtggatggcatcaaacagggcaaagtgttttttattga atgcttataggttttttttaaataagtgggtcaagtacaccagccacctccagacaccagtgcgtgctcccgatgctgc tatggaaggtgctacttgacctaaaggactcccacaacaacaaaagcttgaagctgtggagggccacggtggcgtggct ctcctcgcaggtgttctgggctccgttgtaccaagtggagcaggtggttgcgggcaagcgttgtgcagagcccatagcc agctgggcagggggctgccctctcc Figure 2. Sequence

of Cyclin E

DNA and predicted

protein sequence

of the cyclin E CDNA that complemented

the triple c/n deletion

tgc cys

ctc leu

ctc leu

ccaccccatccttct

gag gfu

Cell 1220

CYCLIN CYCLIN CYCLIN

E A B

CYCLIN CYCLIN CYCLIN

E A B

IlLGNSAPGP IlALR

SKINAENKAKINIiAGAKRVPTAF

CGAEFSARSRKR

E CYCLIN CYCLIN CYCLIN

E A B

E A B

CYCLIN CYCLIN CYCLIN

E A B

CYCLIN CYCLIN CYCLIN

E A B

ET

DR

RGSP-W

V CYCLIN CYCLIN CYCLIN

L

MRAILDWLV

WL

G

AKEEYPP

L

of the Protein Sequences

TD

NE

L

LA

tlYIRETG5SKLK HFRGVADEDAHNIQTHRD

Figure 3. Alignment

F

L

L

Y

&@~~&K~~EQNRAsPLP~GLL~PQ~GKKQssGPE~~A

of Human Cyclins A, B, and E

Protein sequences of cyclins A, B, and E were aligned to maximize homology. Boxes indicate identical amino acids. Amino acids shared by all three cyclins are shown in bold type above the three sequences. The area highlighted by double bold lines is a domain highly conserved among all known cyclins (the cyclin box). The domain highlighted by single bold lines is the mitotic destruction motif shared by all A- and B-type cyclins.

were cloned into the ADH expression vector used in construction of the library described above. The various cyclin expression plasmids were transfected into yeast by selecting for leucine prototrophy. The transformants were picked, and the ability of the human cyclin to complement the absence of the CLN proteins was tested by growth on glucose. No leucine prototrophs were obtained using the cyclin A vector, suggesting that expression of full-length human cyclin A in S. cerevisiae was lethal. Table 1 depicts the relative plating efficiency of 589-5 on glucose versus galactose when containing either cyclin B or E expression plasmids. Surprisingly, the mitotic cyclin B complemented the absence of the CLN proteins. This experiment demonstrated that complementation of CLN function was not restricted to CLN-type cyclins.

Interaction between Cyclin E and CDC28 We compared the ability of cyclin E to rescue the triple c/n deletion in isogenic strains containing either the CDC28 or the c&28-73 allele at the permissive temperature of 30% (Table 1). Table 1 shows that cyclin E substituted for the CLN proteins significantly less well in the c&28-73 background. This genetic interaction between the cyclin E and CDC28 genes suggested that the cyclin E protein performed its function by interacting with the CDC28 protein. Cyclin 6 was about as effective in cdc28-13versus CDC28 strains, suggesting that cyclin B might interact with CDC28 differently than cyclin E.

Human Cyclin E and Human CDCP Can Perform START in S. cerevisiae Strains containing c&28-13 and the endogenous Gl (CLN) and mitotic (CLB) cyclins are viable at 30%. Therefore, the cdc28-13 protein must be capable of functional interactions with both types of cyclins. As described above, a c&28-73 strain that contained cyclin E in place of the CLN genes did not grow at 30%. We speculated that this strain was defective specifically for the START function of the CDC28 protein and not for its G2/M role, presumably because the c&28-73 mutation diminished its ability to interact productively with cyclin E. These properties of the cyclin E-c&2&73 strain are shown in Table 2. We used this strain as a host to screen for human genes that could interact with cyclin E to perform START. Unlike screens requiring human genes to completely substitute for CDC28, this screen may not require that the human genes function at G2/M. We transfected this strain with the human cDNAexpression library described above, and lo5 independent colonies were tested for their ability to grow on glucose. We identified five yeast clones whose growth depended on expression of both the human cDNAs (cyclin E and the new one) (Table 3). The human cDNA within each of these clones was restriction mapped (data not shown). Four of these (S2-8a2, S2-103, S2-112, 52-227) contained the CDC2-HS gene (Lee and Nurse, 1987). The S. pombe cdc2’ gene also performed START together with human cyclin E in this strain (F. C. and A. Tinkelenberg, unpublished data). These results provide

Human Cyclin E 1221

Table 1. Efficiency of Rescue of the Triple c/n Deficiency Human Cyclins E and B in CDCPB or cdc28-73 Strains

pADNS pADANS pADNS-CYC E pADANS-CYC E pADANS-CYC B

CDC28

cdc28-13

Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

A new human cyclin, named cyclin E, was isolated by complementation of a triple cln deletion in S. cerevisiae. Cyclin E showed genetic interactions wi...
2MB Sizes 0 Downloads 0 Views